JENNIFER WOOD: Open Payments
NPI 1215503024 · MARIANNA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 29 payments from 11 companies in 2025. Trend: 2023 $672 · 2024 $944 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $185 |
| Amgen Inc. | 6 | $108 |
| Novo Nordisk Inc | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 3 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: QULIPTA, Ozempic, VRAYLAR, REPATHA, TRELEGY ELLIPTA, OTEZLA, JASCAYD, EVENITY.
Industry payments across FL — which companies pay providers there.
